1. Revocation of a judgment of the first instance;

2. The plaintiff's claim is dismissed.

3. All costs of the lawsuit shall be borne by the Plaintiff.

(b)on the basis of current views on blood testing;

However, if it is not possible to conduct the above pathological diagnosis, the clinical diagnosis of the nature of boundary is recognized as evidence of the form of boundary.

In this case, there shall be a documented record or evidence proving that the insured is under diagnosis or treatment in the form of boundary.

35. According to Article 1 (Indemnification and Termination Date of Guarantee) of the Special Terms and Conditions for Guarantee of Expenses for Cancer Admission (Compensation for Damages) (1) If the insured, after the date of commencement of guarantee stipulated in Article 5 (Time and Termination Date of Guarantee of Company) (1), has diagnosed and confirmed with cancer other than other skin cancer, yeast cancer, sampling cancer, thyeast cancer, or dyeast cancer, or dyeast cancer, and has continued to be hospitalized for at least four days for direct purposes and has received treatment as stipulated in Article 2 (Definition and Place of Hospitalization), the company shall pay to the beneficiary the amount set forth in the following table in accordance with this Special Terms and Conditions:

* When hospitalization is continued for at least four consecutive days due to the boundary nature: 25% of the amount of insurance coverage for cancer hospitalization per day exceeding three days. 2. The number of payment days for cancer hospitalization under paragraph 1 shall be limited to 120 days per time of hospitalization.

36. Under Article 1 of the General Terms and Conditions for Security of Cancer (Compensation for Damages) a company shall pay to the beneficiary the amount of money set forth in the following table in accordance with this Special Terms and Conditions when the insured is diagnosed and finalized with cancer other than other skin cancer, i.e., sampling cancer, Athythyal cancer, i.e., upstream cancer, or dypical dyprypium after the date of commencement of guarantee stipulated in Article 5(1) during the insurance period, and undergo an operation for direct purposes of the treatment.

* At the time of an operation due to boundary species: 25% [Attachment 10] of the purchase amount of insurance coverage for cancer surgery costs is unclear or diseases classified as boundaryal species as prescribed in the terms and conditions of the new life classification table in the U.S. shall be the fifth revision.